Doctor profile · Federal record
Dr. Alkarim Tajuddin, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Elk Grove Village, IL
- NPI 1922069160
- Accepts Medicare
- 39 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
800 Biesterfield RD, Suite 210
Elk Grove Village, IL 600073311
(847) 437-3312
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1922069160. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
97,081
Distinct HCPCS
10
Medicare allowed
$611,262
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 50,250 | 39 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 20,780 | 29 | $3 | |
J1627 |
Injection, granisetron, extended-release, 0.1 mg | 8,700 | 24 | $7 | |
J0185 |
Injection, aprepitant, 1 mg | 5,720 | 13 | $2 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,900 | 39 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,421 | 380 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 716 | 241 | $10 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 652 | 22 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 630 | 12 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 497 | 272 | $133 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 1,525. This provider delivers 64× the peer median.Open Payments
Industry payments received
All-time total
$3,668
Transactions
53
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $1,514.78 | |
| Exelixis Inc. | 1 | $652.95 | |
| PFIZER INC. | 14 | $269.46 | |
| ABBVIE INC. | 5 | $113.94 | |
| Celgene Corporation | 3 | $95.56 | |
| Merck Sharp & Dohme LLC | 4 | $94.17 | |
| Novartis Pharmaceuticals Corporation | 4 | $92.56 | |
| ADC Therapeutics America, Inc. | 1 | $89.55 | |
| Genentech USA, Inc. | 3 | $77.40 | |
| Gilead Sciences, Inc. | 3 | $70.40 | |
| Incyte Corporation | 2 | $51.03 | |
| GlaxoSmithKline, LLC. | 2 | $44.17 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $39.68 | |
| Dendreon Pharmaceuticals LLC | 1 | $33.99 | |
| Blueprint Medicines Corporation | 1 | $31.86 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
482
Patients
126
Total drug cost
$115,028
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prochlorperazine Maleate | Generic | 61 | 30 | $828 |
| Eliquis (Apixaban) | Brand | 60 | 12 | $41,975 |
| Xarelto (Rivaroxaban) | Brand | 59 | 14 | $54,339 |
| Warfarin Sodium | Generic | 54 | 0 | $483 |
| Letrozole | Generic | 46 | 22 | $947 |
| Imatinib Mesylate | Generic | 27 | 0 | $8,946 |
| Hydroxyurea | Generic | 23 | 0 | $754 |
| Prednisone | Generic | 23 | 13 | $231 |
| Dexamethasone | Generic | 22 | 11 | $538 |
| Exemestane | Generic | 20 | 0 | $4,171 |
Hospital affiliations
Frequently asked questions
What is Dr. Alkarim Tajuddin's medical specialty?
Dr. Alkarim Tajuddin practices Hematology & Oncology Physician in Elk Grove Village, IL.
Where does Dr. Alkarim Tajuddin practice?
Dr. Alkarim Tajuddin practices at 800 Biesterfield RD, Elk Grove Village, IL 600073311. Office phone: 8474373312.
What is Dr. Alkarim Tajuddin's NPI?
Dr. Alkarim Tajuddin's National Provider Identifier (NPI) is 1922069160, issued by NPPES.
Does Dr. Alkarim Tajuddin accept Medicare assignment?
Yes. Dr. Alkarim Tajuddin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alkarim Tajuddin commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, granisetron, extended-release, 0.1 mg (HCPCS J1627). Source: CMS Medicare Physician & Other Practitioners file.